Decision regret after external beam radiotherapy and high dose-rate brachytherapy boost for prostate cancer

被引：0
|
作者：
Lars Haack [1 ]
David Krug [1 ]
Severin Rodler [2 ]
Philipp Nuhn [3 ]
Christof van der Horst [3 ]
Christian Schulz [4 ]
Olaf Wittenstein [1 ]
Claudia Schmalz [1 ]
Oliver Blanck [1 ]
Frank-André Siebert [1 ]
Alexander Fabian [1 ]
机构：
[1] University Hospital Schleswig-Holstein Campus Kiel,Department of Radiation Oncology
[2] University Medical Center Hamburg-Eppendorf,Department of Radiotherapy and Radiation Oncology
[3] University Hospital Schleswig-Holstein Campus Kiel,Department of Urology
[4] URODOCK Urology Group Practice,undefined
来源：
World Journal of Urology | / 43卷 / 1期
关键词：
Prostate cancer; Radiotherapy; Brachytherapy; Decision regret; Patient-reported outcome; Health-related quality of life;
D O I：
10.1007/s00345-025-05615-3
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] High-dose-rate brachytherapy in combination with conformal external beam radiotherapy in the treatment of prostate cancer
    Zwahlen, Daniel R.
    Andrianopoulos, Nick
    Matheson, Bronwyn
    Duchesne, Gillian M.
    Millar, Jeremy L.
    BRACHYTHERAPY, 2010, 9 (01) : 27 - 35
  • [22] Clinical outcome in patients with prostate cancer treated with external beam radiotherapy and high dose-rate iridium 192 brachytherapy boost:: A 6-year follow-up
    Kalkner, Karl Mikael
    Wahlgren, Thomas
    Ryberg, Marianne
    Cohn-Cedermark, Gabriella
    Castellanos, Enrique
    Zimmerman, Rolf
    Nilsson, Josef
    Lundell, Marie
    Fowler, Jack
    Levitt, Seymour
    Hellstrom, Magnus
    Nilsson, Sten
    ACTA ONCOLOGICA, 2007, 46 (07) : 909 - 917
  • [23] High-dose-rate brachytherapy combined with external beam radiotherapy for high-risk prostate cancer
    Kariya, S.
    Kobayashi, K.
    Yamasaki, I.
    Ashida, S.
    Tamura, K.
    Inoue, K.
    Shuin, T.
    Yamagami, T.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S950 - S950
  • [24] Low and high-dose-rate brachytherapy in combination with external beam radiotherapy for high risk prostate cancer
    Solodkiy, V. A.
    Pavlov, A. Yu
    Tsibulskii, A. D.
    Panshin, G. A.
    Dzidzaria, A. G.
    Mirzahanov, R., I
    ONKOUROLOGIYA, 2021, 17 (02): : 72 - 82
  • [25] Is single fraction 15 Gy the preferred high dose-rate brachytherapy boost dose for prostate cancer?
    Morton, Gerard
    Loblaw, Andrew
    Cheung, Patrick
    Szumacher, Ewa
    Chahal, Manraj
    Danjoux, Cyril
    Chung, Hans T.
    Deabreu, Andrea
    Mamedov, Alexandre
    Zhang, Liying
    Sankreacha, Raxa
    Vigneault, Eric
    Springer, Colvin
    RADIOTHERAPY AND ONCOLOGY, 2011, 100 (03) : 463 - 467
  • [26] The effectiveness and side effects of conformal external beam radiotherapy combined with high-dose-rate brachytherapy boost compared to conformal external beam radiotherapy alone in patients with prostate cancer
    Smolska-Ciszewska, Beata
    Miszczyk, Leszek
    Bialas, Brygida
    Fijalkowski, Marek
    Plewicki, Grzegorz
    Gawkowska-Suwinska, Marzena
    Giglok, Monika
    Behrendt, Katarzyna
    Nowicka, Elzbieta
    Zajusz, Aleksander
    Suwinski, Rafal
    RADIATION ONCOLOGY, 2015, 10
  • [27] The effectiveness and side effects of conformal external beam radiotherapy combined with high-dose-rate brachytherapy boost compared to conformal external beam radiotherapy alone in patients with prostate cancer
    Beata Smolska-Ciszewska
    Leszek Miszczyk
    Brygida Białas
    Marek Fijałkowski
    Grzegorz Plewicki
    Marzena Gawkowska-Suwińska
    Monika Giglok
    Katarzyna Behrendt
    Elżbieta Nowicka
    Aleksander Zajusz
    Rafał Suwiński
    Radiation Oncology, 10
  • [28] ACUTE TOXICITY OF SINGLE FRACTION HIGH DOSE-RATE BRACHYTHERAPY WITH HYPO-FRACTIONATED EXTERNAL BEAM RADIOTHERAPY IN INTERMEDIATE RISK PROSTATE CANCER
    Kamran, A.
    Morton, G.
    Loblaw, A.
    Sankreacha, R.
    Su, D.
    Gardner, S.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S41 - S41
  • [29] Acute Toxicity after Single Fraction High Dose Rate Brachytherapy with External Beam Radiotherapy in Intermediate and High Risk Prostate Cancer
    Alam, N.
    Taylor, C.
    Mandall, P.
    James, L.
    Logue, J.
    Wylie, J.
    CLINICAL ONCOLOGY, 2009, 21 (10) : 799 - 799
  • [30] After low and high dose-rate interstitial brachytherapy followed by IMRT radiotherapy for intermediate and high risk prostate cancer
    Satoshi Nakamura
    Naoya Murakami
    Koji Inaba
    Akihisa Wakita
    Kazuma Kobayashi
    Kana Takahashi
    Hiroyuki Okamoto
    Rei Umezawa
    Madoka Morota
    Minako Sumi
    Hiroshi Igaki
    Yoshinori Ito
    Jun Itami
    BMC Cancer, 16
12345